The development of the brain requires the exquisite coordination of progenitor proliferation and differentiation to achieve complex circuit assembly. It has been suggested that glycogen synthase kinase 3 (GSK-3) acts as an integrating molecule for multiple proliferation and differentiation signals because of its essential role in the RTK, Wnt and Shh signaling pathways. We created conditional mutations that deleted both the  and  forms of GSK-3 in mouse neural progenitors. GSK-3 deletion resulted in massive hyperproliferation of neural progenitors along the entire neuraxis. Generation of both intermediate neural progenitors and postmitotic neurons was markedly suppressed. These effects were associated with the dysregulation of -catenin, Sonic Hedgehog, Notch and fibroblast growth factor signaling. Our results indicate that GSK-3 signaling is an essential mediator of homeostatic controls that regulate neural progenitors during mammalian brain development.
a r t I C l e S GSK-3 is a serine-threonine kinase with established roles in receptor tyrosine kinase and Wnt/Frizzled signaling. In mammals, the GSK-3 family consists of two members, GSK-3α and GSK-3β, which have 98% sequence identity in their kinase domains. Recent studies that have mostly used pharmacological approaches have suggested that GSK-3 is important in an array of settings including regulation of transcription factor levels in multiple signaling pathways, cell polarity and neurotransmitter signaling [1] [2] [3] . Recently, pharmacological evidence has implicated GSK-3 signaling in the regulation of embryonic stem cell self-renewal [4] [5] [6] . Furthermore, it has been suggested that the Deleted in Schizophrenia (DISC1), which has been implicated in some familial cases of schizophrenia and depression, regulates neural progenitor proliferation and may act in part via regulation of GSK-3 activity 7 . These observations raise the question of how GSK-3 functions in relation to neural progenitor self-renewal and neurogenesis during brain development.
Development of the brain requires exquisite coordination of progenitor proliferation and differentiation to achieve optimized functional potential. Recently, multiple signaling pathways, including Wnts, fibroblast growth factors (FGFs), Sonic Hedgehog (Shh) and Notch, have been identified as regulating neural progenitors 8 . However, the manner in which these signals are coordinated to achieve exquisite spatial and temporal control over neurogenesis is unknown. GSK-3s are uniquely well-positioned to coordinate multiple proliferation and differentiation signals because they potentially regulate critical nodes in each of these pathways. Inhibition of GSK-3 is critical to canonical Wnt signaling leading to increased β-catenin levels in all of the cell types studied to date 1 . Furthermore, GSK-3 is inhibited downstream of FGF signaling via phosphatidylinositol-3 kinase (PI3K) 9 . Several recent studies in cell lines have demonstrated GSK-3 regulation of Myc family proteins via the PI3K pathway [10] [11] [12] [13] . In Drosophila, it is known that the GSK-3 homolog Shaggy regulates Hedgehog signaling 14 . Finally, several studies in cell lines have demonstrated that GSK-3 inhibition modulates the Notch pathway [15] [16] [17] . To date, however, the effects of deleting GSK-3 specifically in neural progenitors on signaling via these pathways and on progenitor self-renewal and subsequent brain development have not been determined.
We used a conditional knockout strategy in a Gsk3a null background to specifically target Gsk3b in the developing nervous system. We found that GSK-3-deficient progenitors were locked into the radial progenitor phase, as generation of both intermediate neural progenitors (INPs) and postmitotic neurons was markedly suppressed. Our findings suggest that GSK-3 deletion removes homeostatic controls on neural progenitors, shifting the balance toward self-renewal and away from neurogenesis.
RESULTS

GSK-3 deletion markedly enhances progenitor proliferation
To investigate the functions of GSK-3 in the developing mammalian nervous system, we generated Gsk3a −/− (Gsk3a null) and Gsk3b loxP/loxP mice and crossed these with a well-characterized nestin-cre line that drives expression of Cre recombinase in CNS progenitors from about embryonic day 10 (E10) 18, 19 . Gsk3a null mice that harbored an exon 2 deletion and Gsk3b loxP/loxP mice were generated by flanking exon 2 with loxP sites (Supplementary Fig. 1 ) 20, 21 . Neither Gsk3a null nor Gsk3b loxP/loxP ; nestin-cre mice had major brain developmental malformations (W.-Y.K. and W.D.S., unpublished observations) 22 . Western blots showed that the α and β forms of GSK-3 were eliminated in the developing brains of Gsk3a −/− ; GSK Gsk3b loxP/loxP ; nestin-cre mice (Supplementary Fig. 1 ). Compared with the control a r t I C l e S littermates (Gsk3a +/− ; Gsk3b loxP/+ ; nestin-cre), Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre mice had bigger heads (Supplementary Fig. 1 ) at every developmental stage from E12.5 until they died at P0. Brains from control mice had smooth and straight cortices in coronal sections at E13.5 ( Supplementary Fig. 1 ), whereas the brains of Gsk3a −/− Gsk3b loxP/loxP ; nestin-cre mice were markedly convoluted. Gsk3a −/− Gsk3b loxP/loxP ; nestin-cre brains also showed substantially enlarged ventral brain areas, including the ganglionic eminence and ventral thalamus (Supplementary Fig. 1 ). We measured the ventricular apical surface lengths and found a 2.7-fold increase in GSK-3-deleted brains compared with control brains (Supplementary Fig. 1) .
To explore the basis of the convoluted cortex, we assessed neural progenitors in the Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre brain using an antibody to Sox2, a neural progenitor marker. In control brains at E13.5, Sox2-positive progenitors were distinctly distributed surrounding the ventricles (Fig. 1a) . We also observed Sox2 expression in a limited part of the dorsal ganglionic eminence. In Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre brains, Sox2-positive neural progenitor pools were massively expanded (Fig. 1a) . At the level of ganglionic eminence, this expansion was also prominent in ventral forebrain. We observed this progenitor expansion at every rostro-caudal level that we examined, including spinal cord (Fig. 1a) .
To further assess this hyperproliferation, we measured the proportion of cells in various cell-cycle phases at E13.5. Twice as many cells were positive per coronal section for the mitotic marker phospho-histone H3 in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre cerebral cortex compared with controls (Fig. 1b,c and Supplementary Fig. 2 ). Western blotting confirmed that phospho-histone H3 expression was markedly increased (Supplementary Fig. 2 ). We then assessed the numbers cells in S phase after a short-term BrdU pulse. The number of BrdU-positive S phase cells was also increased (Fig. 1b,c and Supplementary Fig. 2 ). These results indicate that many more cells were undergoing division in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre brains than in controls at E13.5. To further identify the underlying causes of the expansion of the progenitor pool, we investigated cell-cycle length and re-entry. The number of Ki67 and BrdU double-positive cells after short and long BrdU pulses in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre cortex was increased (Fig. 1c) a r t I C l e S of the cell cycle and increased cell-cycle re-entry. Immunostaining and western blotting with an antibody to activated caspase-3 revealed that levels of apoptosis were not significantly different between control and mutant cortex at E13.5 (P < 0.01; Fig. 1c and Supplementary  Fig. 2 ). Taken together, these results indicate that the expanded progenitor pool in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre brain is the result of increases in cell-cycle rate and re-entry, but not of enhanced progenitor survival.
GSK-3 deletion strongly Inhibits neurogenesis
To assess the progression of the radial progenitors to INPs, we immunostained cerebral cortex samples using an antibody to Tbr2, a specific marker for INPs 23 . To our surprise, we found that the number of Tbr2-positive cells was reduced by 64% (±2.7%) in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre cortices (Fig. 2a) . Western blotting showed that the level of Tbr2 in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre brain was markedly decreased (Fig. 2b) . Our results indicate that GSK-3 activity is required to regulate the conversion of Sox2-positive radial progenitors into INPs during cortical development.
We next examined the number of neurons in both control and mutant sections using immunostaining with an antibody to Tuj1 that recognizes postmitotic neurons. The numbers of Tuj1-positive neurons were decreased by about 60% in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre cortical sections (Fig. 3) . We observed similar decreases with Tbr1 and NeuN, two commonly used neuronal markers ( Fig. 3b-d) . These morphological results were confirmed by western blotting. The levels of the neuronal makers Tuj1, MAP2, SMI32 and NeuN in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre brain tissue were all reduced by 50-70% (Fig. 3e,f) . In contrast, the progenitor markers Nestin and Pax6 were upregulated by 100-200%. Together, these results indicate that GSK-3 is required for proper regulation of neurogenesis in the developing mouse brain.
To assess the effects on neurogenesis over time, we examined Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre brains at multiple rostro-caudal levels at E15.5 (Fig. 4) . Notably, we observed that there was massive expansion of the area filled with Sox2-positive cells throughout the telencephalon in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre cortical wall in comparison with controls, where Sox2-positive progenitors were restricted to regions surrounding the ventricles ( Fig. 4a-d) . Neurogenesis in GSK-3 mutant brains at this age was strongly suppressed, as marked by Tuj1 staining (Fig. 4e,f) . Thus, inhibition of neurogenesis is persistent in the absence of GSK-3 signaling.
One implication of our findings is that GSK-3 activity toward substrates that influence proliferation may be upregulated as the progenitor proliferation diminishes and as neurogenesis proceeds. To assess this idea in a general way, we measured the phosphorylation levels of c-Myc and β-catenin, GSK-3 targets, at three developmental stages, E13, E15 and E17. Both phospho-c-Myc and phospho-β-catenin levels in brain lysates were increased with increasing embryonic age ( Supplementary  Fig. 3 ), suggesting that GSK-3 activity toward the proliferation regulators c-Myc and β-catenin is suppressed during the period of active progenitor proliferation and increased at later stages.
Activation of -catenin, Shh and Notch signaling
To determine whether Wnt signaling is involved in the expansion of the progenitor pool in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre brains, we first examined the expression levels and the distribution patterns of β-catenin. In controls, β-catenin was highly enriched along the apical surface (Fig. 5a) . However, in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre brains, β-catenin was highly expressed throughout the thickness of the developing cortex (Fig. 5a) . We also observed a similar loss of the normal spatial expression pattern and an increase in the levels of β-catenin in the spinal cord ( Supplementary Fig. 4) . At the single-cell level, we found an increased level of β-catenin in both the nucleus and the cytosol in GSK-3 mutant brains (Fig. 5a) , indicating accumulation and translocation of β-catenin from the cytosolic compartment to the nucleus. Western blots showed that total levels of β-catenin and its transcriptional targets Axin2 and c-Jun were increased in Gsk3a −/− ; a r t I C l e S Gsk3b loxP/loxP ; nestin-cre brains (Fig. 5b) . Together, these data indicate that β-catenin is markedly dysregulated in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre neural progenitors and suggest that β-catenin/TCF/LEF1 signaling is hyperactive in these cells. To further investigate the mechanisms responsible for the expanded progenitor pool, we examined Shh signaling. We first examined overall levels of Shh downstream effectors, Gli1 and Gli2 proteins in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre brains at E14.5. Western blots showed that levels of Gli1 and Gli2 were markedly increased, whereas levels of Gli3 were unchanged (Fig. 5) . Gli1 has been demonstrated to be a direct transcriptional target of Gli2 in neural and non-neural systems 24 . Therefore, we determined the distribution patterns of Gli1 mRNAs in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre brains using in situ hybridization. Gli1 was strongly expressed in the ventricular/subventricular zone of GSK-3 mutant dorsal telencephalon, whereas there was little expression in control dorsal telencephalon (Fig. 5d) . Furthermore, we found a massive expansion of Gli1 expression in mutant ventral telencephalon (Fig. 5d) . Patched, a transcriptional target of Shh signaling 24 , was also markedly upregulated, particularly in dorsal regions of the ganglionic eminence (Fig. 5d) . The increased levels of Shh components were not associated with Shh protein levels, as no changes were found in Shh expression between control and GSK-3-deleted brain samples (Supplementary Fig. 5 ). To test whether the increases in the levels of Shh components are functionally relevant, we knocked downed Gli1 in dissociated Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre progenitors using small interfering RNA to Gli1. The siRNA decreased the progenitor proliferation by about 35% compared with controls ( Supplementary Fig. 5 ). These data indicate that Shh signaling is constitutively activated in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre brains and that Shh signaling is important in mediating GSK-3 deletion effects.
Finally, to determine whether there may be abnormal activation of Notch signaling in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre brains, we examined the expression level and distribution pattern of Hes1, a Notch downstream mediator. Hes1 expression is normally restricted to the ventricular and subventricular zones (Fig. 6a) . However, we found that Hes1 was distributed throughout the width of the cerebral cortical wall of GSK-3 mutants. The overall levels of Hes1 and Hes5 were also substantially increased in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre brain lysates (Fig. 6b) . The widespread distribution and upregulation of Hes1 suggests that the Notch pathway is activated in the developing cortex of Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre embryos. To address this possibility, we measured the amount of cleaved intracellular domain of Notch (NICD, activated form of Notch) that was present. We found that, compared with control brains, the amount of NICD in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre brains was markedly increased (Fig. 6c) Fig. 6 ). We conclude that inactivation of endogenous GSK-3 enhances Notch signaling, which then inhibits neurogenesis in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre mice.
. To assess the increase in Notch signaling is functionally relevant, we treated GSK-3-deleted progenitors with the gamma secretase inhibitor N-[N-(3,5-difluorophenacetyl-L-alanyl)]-Sphenylglycine t-butyl ester (DAPT). This treatment reduced the hyperproliferation and increased the number of MAP2-positive neurons (Supplementary
Both constitutive and targeted activation of β-catenin enhances the proliferation of neural progenitors 25, 26 . These findings raise the questions of whether the effects of GSK-3 deletion that we observed are entirely mediated by increased levels of β-catenin. To address this issue, we inhibited β-catenin signaling by transfecting dissociated Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre cortical progenitors with a dominantnegative TCF (dnTCF) construct that lacks the N-terminal sequences required for β-catenin binding 27 . Overexpression of dnTCF only partially inhibited proliferation of GSK-3-deleted progenitors, reducing proliferation markers by about 50% (Fig. 6d,e) . The percentage of proliferating cells was still almost twice as high as that of controls (Supplementary Fig. 6 ). Thus, a substantial fraction of GSK-3-deleted progenitors continued to proliferate when β-catenin signaling was suppressed. Notably, inhibition of Notch signaling by transfection of a dominant-negative Hes1 (dnHes1) also resulted in reductions of progenitor proliferation by around 50% (Fig. 6d,e) . However, inhibition of both β-catenin and Notch signaling reduced proliferation in GSK-3-deleted cells to levels below 5% (Fig. 6d,e) . These results are consistent with the idea that independent regulation of β-catenin and Notch signaling mediate GSK-3's effects.
GSK-3 regulation of c-Myc downstream of FGF/PI3K
Myc family proteins are critical for the regulation of proliferation in multiple settings and GSK-3 has been shown to directly regulate the stability of both c-Myc and the related family member N-Myc in cell lines 10 . We stained Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre progenitors with an antibody to c-Myc and found that there was a massive a r t I C l e S accumulation of c-Myc proteins in the nucleus (Fig. 7a) . Western blots confirmed the major increase of c-Myc and N-Myc in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre brain samples that we observed (Fig. 7b) . GSK-3 phosphorylation of c-Myc (and N-Myc) at T58 is thought to promote c-Myc degradation through ubiquitin-proteasome machinery. We found that T58 phosphorylation was almost completely abrogated in GSK-3 mutant brain samples, as predicted (Fig. 7b) . To test whether the increase in c-Myc levels is functionally relevant, we inhibited c-Myc function in dissociated Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre progenitors with a dominant-negative c-Myc (dnc-Myc) construct in a procedure similar to the one outlined above for β-catenin. Overexpression of dnc-Myc decreased progenitor proliferation by 41 ± 5% compared with a green fluorescent protein (GFP) overexpression control.
GSK-3 regulation of Myc protein stability is thought to occur downstream of PI3K signaling. A logical candidate to regulate this signaling would be the FGFs, which are known to regulate progenitor proliferation in the developing telencephalon via receptor tyrosine kinases 8 . Therefore, we examined the possibility that GSK-3 mediates FGF-PI3K signaling in the regulation of neural progenitor proliferation. We assessed progenitor proliferation in control and GSK-3-deficient cortical cultures after treatment with FGF2 and/or LY294002. As expected, addition of FGF2 increased progenitor proliferation in control cultures (data not shown). Treatment with LY294002 decreased the numbers of BrdU-positive proliferating progenitors in FGF2-treated control cultures by more than 50% (Fig. 7c,d) . Notably, the inhibitory effects of LY294002 were completely suppressed in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre cortical cultures.
We next assessed c-Myc levels in cortical cultures while inhibiting PI3K and stimulating FGF. Treatment of control cortical cultures with LY294002 substantially decreased c-Myc levels ( Supplementary  Fig. 7) . As expected, phosphorylation of c-Myc at T58 and GSK-3β at S9 were increased and decreased, respectively. These results suggest that inhibition of PI3K decreases c-Myc levels by enhancing GSK-3 activity. To address this possibility, we performed the same experiments in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre cortical cultures. The decrease in c-Myc levels that we observed with LY294002 treatment was abolished in the lysates of GSK-3β-deleted cultures (Fig. 7e) . To assess the potential regulation of c-Myc levels by FGF2, we treated cortical cultures with FGF2. Treatment with FGF2 markedly upregulated c-Myc and this was inhibited by LY294002 (Fig. 7f) . The increase of c-Myc in GSK-3-deficient cortical cells was not affected by treatment with either FGF2 or FGF2 and LY294002 (Fig. 7f) . Taken together, these results strongly suggest that GSK-3 mediates FGF-PI3K regulation of c-Myc.
Multiple studies have shown that appropriate apical-basal polarity of progenitors is required for normal neurogenesis 28 . To address progenitor polarity, we stained brain tissues with antibodies against multiple cell polarity and adhesion markers including PKCζ, Fig. 8 ). These results demonstrate that GSK-3 signaling is essential for apical-basal polarity in the developing cortex and suggest that GSK-3 may control progenitor proliferation in part by organizing cellular polarity.
DISCUSSION
GSK-3 is an important molecular regulator of neurogenesis
We found that deletion of GSK-3 massively expanded the radial progenitor pool. The elimination of either GSK-3 family member alone or the elimination of three Gsk3 alleles had no obvious effect. This suggests that a major reduction of GSK-3 signaling is required to remove critical GSK-3-mediated homeostatic controls during embryonic brain development. Determination of the mitotic index with phospho-histone H3, BrdU and Ki67 labeling indicated that premature re-entry and shortening of the cell cycle occurred in progenitors in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre mice. Shortened cell cycle has previously been implicated in reduced responsiveness to differentiation signals and it has been suggested that cell-cycle regulation is an important control point for mechanisms that account for differences in neuron number between rodents and primates 29 . In contrast with the expansion of Sox2-positive radial progenitors, generation of neurons and INPs was markedly reduced in the absence of GSK-3. Thus, neural differentiation was arrested at the radial progenitor stage. The effects of GSK-3 deletion on proliferation and differentiation that we observed suggest that temporal and spatial regulation of GSK-3 activity during nervous system development is required to terminate proliferation and allow differentiation at just the right moment to yield the correct number of neurons. Our results raise the possibility that regulation of the activity of a single kinase provides a powerful and simple mechanism for controlling neuron number.
GSK-3 deletion removes multiple homeostatic controls
The extent to which the multiple mechanisms that are known to regulate neural progenitors operate independently or are coordinately regulated is unclear. GSK-3 has the, to the best of our knowledge, unique potential to control each of these critical homeostatic mechanisms.
Dysregulation of β-catenin levels is likely to be important for the hyperproliferation of progenitors that we observed. Our findings are entirely consistent with the notion that appropriate regulation of β-catenin is critical for the control of progenitor proliferation in multiple regions of the developing nervous system 7, 25, 26, [30] [31] [32] . Shh signaling is also affected by GSK-3 deletion. Our results suggest that there is a mammalian counterpart of the Drosophila GSK-3 homolog Shaggy, which regulates cubitus interruptus (a homolog of mammalian Gli proteins) in the Drosophila Hedgehog signaling pathway 14 . The increased proliferation and regulation of Shh signaling components observed in the ventral telencephalon of GSK-3-deleted mutants strongly suggest that GSK-3 is a critical mediator of Shh signaling in this region. GSK-3 is therefore a candidate for integrating Wnt/β-catenin and Shh signaling pathways, both of which are known to control neurogenesis in the ventral telencephalon 32 .
Our data also indicate that Notch signaling is increased in GSK-3-deficient brains. Notch signaling is known to be important for the maintenance of 'stemness' and the identity of radial glial cells during a r t I C l e S development [33] [34] [35] . Notably, Notch signaling levels distinguish radial progenitors from INPs that have attenuated canonical Notch signaling 34 . Our results are consistent with the idea that high levels of Notch signaling in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre cells suppress neurogenesis at the stage of radial progenitors as they self-renew and that few cells progress to become Tbr2-positive INPs.
n T C F , d n H e s d n H e s d n T C F
Potential interactions among GSK-3-regulated pathways
An important issue is whether GSK-3 regulation leads to a hierarchy of signaling mechanisms that regulate progenitor proliferation or whether multiple GSK-3-regulated mechanisms each contribute independently to the final outcome. There is some evidence that β-catenin can influence Notch signaling and can be regulated by the FGF pathway 9 . However, we doubt that stabilization of β-catenin alone fully accounts for the effects that we describe here and suggest that several other GSK-3-regulated mechanisms exert independent effects. Elimination of β-catenin in neural progenitors reduces, but does not eliminate, progenitor proliferation in vivo 30, 32 . Our data indicate that overexpression of dnTCF only partially inhibits proliferation in Gsk3a −/− ; Gsk3b loxP/loxP ; nestin-cre neural progenitors in vitro. These results suggest that GSK-3 deletion may result in effects on Notch signaling that are independent of β-catenin. Several studies have suggested that GSK-3 may directly regulate Notch signaling via phosphorylation of Notch1 or Notch2, or regulate the actions of the gamma secretase presenillin-1 (refs. [15] [16] [17] . However, all of this work has been carried out in cell lines and the importance of these findings in vivo is unclear.
Finally, our data indicate that GSK-3 strongly regulates Myc family proteins and that FGF regulation of c-Myc via PI3K signaling is disrupted by GSK-3 deletion. Myc family proteins are critical for the regulation of proliferation in multiple settings and a Myc family member, N-Myc, is known from mouse genetic studies to be required for the maintenance of neural progenitor proliferation in cerebellum and cortex 10 . Because c-Myc is thought to be a transcriptional target of β-catenin 36, 37 , at least some of the observed increase of c-Myc in GSK-3-deleted progenitors may be attributable to β-catenin effects. However, we found another mechanism of c-Myc regulation, in which FGF-PI3K controls c-Myc levels via GSK-3. Our findings are consistent with work in cell lines demonstrating that GSK-3 signaling can directly regulate the stability of Myc family proteins via PI3K signaling [11] [12] [13] . Indeed, we found that GSK-3 phosphorylation of c-Myc at T58, which is thought to be important for its stability, is regulated by PI3K. This FGF-PI3K-GSK-3 regulation of Myc protein stability in neural progenitors is likely to be critical for determining its effects, as the half-life of Myc protein in cell lines is extraordinarily brief, on the order of 20 min 38 . 
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